BeOne Medicines (ONC) EBT Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -2,820.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1,558.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -683.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,688.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,526.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,526.00 |
| Dec 31, 2025 | 1,753.00 |
| Sep 30, 2025 | 2,023.00 |
| Jun 30, 2025 | 1,897.00 |
| Mar 31, 2025 | 3,426.00 |
| Dec 31, 2024 | 4,772.00 |
| Sep 30, 2024 | -3,917.00 |
| Jun 30, 2024 | 5,033.00 |
| Mar 31, 2024 | 4,286.00 |
| Dec 31, 2023 | 5,809.00 |
| Sep 30, 2023 | 17,156.00 |
| Jun 30, 2023 | 10,151.00 |
| Mar 31, 2023 | 6,214.00 |
| Dec 31, 2022 | 16,984.00 |
| Sep 30, 2022 | 6,758.00 |
| Jun 30, 2022 | 15,716.00 |
| Mar 31, 2022 | -14,759.00 |
| Dec 31, 2021 | 19,827.00 |
| Sep 30, 2021 | 26,786.00 |
| Jun 30, 2021 | 19,426.00 |
| Mar 31, 2021 | 70,824.00 |
| Dec 31, 2020 | 18,702.00 |
| Sep 30, 2020 | 14,435.00 |
| Jun 30, 2020 | -45,877.00 |
| Mar 31, 2020 | -48,276.00 |
| Dec 31, 2019 | -19,936.00 |
| Sep 30, 2019 | -35,455.00 |
| Jun 30, 2019 | 24,917.00 |
| Mar 31, 2019 | 11,821.00 |
| Dec 31, 2018 | 5,007.00 |
| Sep 30, 2018 | -31,932.00 |
| Jun 30, 2016 | -569,530.00 |
| Mar 31, 2016 | -250,274.00 |